Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.

Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A.

Histopathology. 2012 Jun;60(7):1045-51. doi: 10.1111/j.1365-2559.2012.04188.x. Epub 2012 Feb 20.

PMID:
22348590
2.
3.

Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.

Cancer. 2003 Mar 1;97(5):1186-94.

4.

Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.

Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA.

Cancer. 2006 Mar 15;106(6):1286-95.

5.

The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB.

Cancer. 1998 Jan 15;82(2):375-88.

PMID:
9445196
6.

Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.

Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA.

Endocr Pathol. 2015 May;26(2):164-9. doi: 10.1007/s12022-015-9367-6.

PMID:
25898815
7.

Hürthle cell carcinoma: a clinicopathological study of thirteen cases.

Ozlem Küçük N, Kulak H, Tokmak E, Tar P, Ibiş E, Aras G.

Nucl Med Commun. 2006 Apr;27(4):377-9.

PMID:
16531925
8.

Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.

Woodford RL, Nikiforov YE, Hunt JL, Bellizzi AM, Zhang X, Mills SE, Stelow EB.

Am J Surg Pathol. 2010 Nov;34(11):1582-90. doi: 10.1097/PAS.0b013e3181f2d820.

PMID:
20924280
9.

Oncocytic carcinoma of the breast: frequency, morphology and follow-up.

Ragazzi M, de Biase D, Betts CM, Farnedi A, Ramadan SS, Tallini G, Reis-Filho JS, Eusebi V.

Hum Pathol. 2011 Feb;42(2):166-75. doi: 10.1016/j.humpath.2010.07.014. Epub 2010 Nov 26.

PMID:
21111455
10.

Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.

Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV.

Mod Pathol. 2010 Sep;23(9):1269-78. doi: 10.1038/modpathol.2010.117. Epub 2010 Jun 18.

11.

Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.

Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM.

Cancer. 2008 Jul 1;113(1):48-56. doi: 10.1002/cncr.23515.

12.

Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?

Dettmer M, Schmitt A, Steinert H, Haldemann A, Meili A, Moch H, Komminoth P, Perren A.

Am J Surg Pathol. 2011 Dec;35(12):1866-72. doi: 10.1097/PAS.0b013e31822cf962.

PMID:
21989341
13.

The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.

Sheu SY, Handke S, Bröcker-Preuss M, Görges R, Frey UH, Ensinger C, Ofner D, Farid NR, Siffert W, Schmid KW.

J Pathol. 2007 Jan;211(1):60-6.

PMID:
17136758
14.

Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.

Siironen P, Hagström J, Mäenpää HO, Louhimo J, Heikkilä A, Heiskanen I, Arola J, Haglund C.

Oncology. 2010;79(5-6):400-8. doi: 10.1159/000322640. Epub 2011 Mar 31.

PMID:
21455012
15.

Cell size as a prognostic factor in oncocytic poorly differentiated carcinomas of the thyroid.

Asioli S, Righi A, Volante M, Chiusa L, Lloyd RV, Bussolati G.

Hum Pathol. 2014 Jul;45(7):1489-95. doi: 10.1016/j.humpath.2014.02.027. Epub 2014 Mar 14.

PMID:
24745614
16.

[Differentiated thyroid carcinoma: survival and prognostic factors].

Sastre Marcos J, Llamazares Iglesias O, Vicente Delgado A, Marco Martínez A, Cánovas Gaillemin B, Orradre Romero JL, Morlan López MÁ, López López J.

Endocrinol Nutr. 2011 Apr;58(4):157-62. doi: 10.1016/j.endonu.2011.01.007. Epub 2011 Mar 17. Spanish.

PMID:
21419724
17.

Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis.

Arora S, Christos P, Pham A, Desai P, Wernicke AG, Nori D, Chao KS, Parashar B.

J Cancer Res Ther. 2014 Jul-Sep;10(3):526-30. doi: 10.4103/0973-1482.138207.

18.

Cytology of "clear cell" variant of oncocytic/Hürthle cell carcinoma of the thyroid.

Sturgis CD, Chang HS, Boudousquie AC.

Diagn Cytopathol. 2011 Aug;39(8):595-7. doi: 10.1002/dc.21476. Epub 2010 Nov 2. No abstract available.

PMID:
21761577
19.
20.

Hürthle cell tumors: applying molecular markers to define a new management algorithm.

Maxwell EL, Palme CE, Freeman J.

Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):54-8.

PMID:
16415430

Supplemental Content

Support Center